Value of P-Glycoprotein and Clinicopathologic Factors as the Basis for New Treatment Strategies in High-Grade Osteosarcoma of the Extremities

This publication has 29 references indexed in Scilit:

• Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute
  Annals of Oncology, 2001
• Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report
  Journal of Clinical Oncology, 2000
• Osteosarcomas and other cancers of bone
  Current Opinion in Oncology, 2000
• P‐glycoprotein expression in osteosarcoma: A basis for risk‐adapted adjuvant chemotherapy
  Journal of Orthopaedic Research, 1999
• On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy
  European Journal Of Cancer, 1997
• Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
  The Lancet, 1997
• Prognostic factors in osteosarcoma: a critical review.
  Journal of Clinical Oncology, 1994
• Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin
  Cancer, 1993
• Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
  Journal of Clinical Oncology, 1992
• Osteosarcoma: Fifteen Years Later
  New England Journal of Medicine, 1985